DEUTSCHE BANK AG\
BankPosition in BHC — Bausch Health Companies Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in BHC
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$200,798
+$85,795 QoQ
Shares Held
40,730
+91.2% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#123
of 220 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Derivatives in BHC
reported options exposure · as of Jun 30, 2026CallValue
$4,930,000
CallShares
1,000,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $1,001,919,079 across 44 Drug Manufacturers - Specialty & Generic names. BHC ranks #36 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,851,737 | $420,505,812 | |
| 2 | VTRS |
Viatris Inc
|
7,891,271 | $125,313,379 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
195,269 | $105,802,598 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,037,225 | $102,901,179 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
334,650 | $56,401,907 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
248,743 | $27,595,547 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
323,443 | $26,774,610 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
387,606 | $24,787,402 |
All Filings in BHC
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,930,000 | 1,000,000 | Call | Defined | 2026-08-07 | |
| 2026-06-30 | $200,798 | 40,730 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $115,003 | 21,297 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $142,780 | 20,544 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $132,508 | 20,544 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $120,705 | 18,124 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $197,295 | 30,494 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $17,165,470 | 2,129,711 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $20,973,982 | 2,570,341 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $20,333,866 | 2,917,341 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $15,425,390 | 1,453,854 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $5,333,692 | 665,049 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,982,627 | 362,850 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $40,000 | 5,000 | Call | Defined | 2023-08-14 | |
| 2023-06-30 | $153,808 | 19,226 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $151,154 | 18,661 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $75,743 | 12,061 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,954,607 | 283,688 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,590,602 | 309,881 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $7,116,310 | 311,436 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $8,440,953 | 305,721 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $9,608,052 | 344,993 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $10,428,740 | 355,687 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $8,772,299 | 276,380 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $5,614,750 | 269,940 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $13,497,341 | 868,555 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $16,044,405 | 877,223 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $16,477,087 | 1,063,038 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||